Startseite The current status of serum insulin measurements and the need for standardization
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The current status of serum insulin measurements and the need for standardization

  • Curt Rohlfing , Gregory Petroski , Maya Hatten-Beck , Steven Hanson , Andrew N. Hoofnagle , Randie R. Little und Kuanysh Kabytaev ORCID logo EMAIL logo
Veröffentlicht/Copyright: 14. August 2025
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Objectives

Insulin assays are used to assess insulin resistance and to aid in the diagnosis of conditions such as insulinoma and various forms of hypoglycemia. However, discrepancies among commercial assays limit their clinical and research utility. This study evaluates the current comparability of the most widely used insulin assays.

Methods

Forty serum samples, including those from healthy individuals and patients with type 1 or type 2 diabetes, were analyzed by nine manufacturers using 12 commercial immunoassays. Results from each assay were compared both to the isotope dilution mass spectrometry (IDMS) method and across the different immunoassays.

Results

Intra-assay repeatability was excellent (ICCs>0.99), but substantial inter-assay variability was observed. Differences relative to LC-MS ranged from −298.2 to +302.6 pmol/L. Several assays overestimated insulin concentrations at low levels and underestimated them at higher levels. Only one assay method showed full agreement with the IDMS method.

Conclusions

Despite all methods claiming traceability to the WHO 66/304 standard, significant variability persists among insulin assays. These findings highlight the urgent need for insulin assay standardization using commutable certified reference materials.


Corresponding author: Kuanysh Kabytaev, Department of Pathology & Anatomical Sciences, University of Missouri, 1 Hospital Drive, Columbia 65211, MO, USA, E-mail:

Funding source: National Institute of Health

Award Identifier / Grant number: 5U01DK133106-03

Award Identifier / Grant number: U01 DK137097

Acknowledgments

We would like to acknowledge the following manufacturers for their participation in our study: Abbott Laboratories, Beckman Coulter Inc., DiaSorin Deutschland GmbH, QuidelOrtho, Fujirebio Inc., Siemens Healthineers, Tosoh Corporation, Mercodia AB, and Roche Diagnostics GmbH.

  1. Research ethics: The protocols were approved by the University of Missouri Health Sciences Institutional Review Board (#2031722).

  2. Informed consent: Informed consent was obtained from all individuals included in this study.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: Not applicable.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: This work was supported by NIH [Grant Number 5U01DK133106-03, U01 DK137097].

  7. Data availability: Not applicable.

References

1. Proud, CG. Regulation of protein synthesis by insulin. Biochem Soc Trans 2006;34:213–6. https://doi.org/10.1042/bst0340213.Suche in Google Scholar

2. Carpentier, AC. 100th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism. Am J Physiol Endocrinol Metab 2021;320:E653–70. https://doi.org/10.1152/ajpendo.00620.2020.Suche in Google Scholar PubMed

3. Czech, MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med 2017;23:804–14. https://doi.org/10.1038/nm.4350.Suche in Google Scholar PubMed PubMed Central

4. Cantley, J, Ashcroft, FM. Q&A: insulin secretion and type 2 diabetes: why do β-cells fail? BMC Biol 2015;13:33. https://doi.org/10.1186/s12915-015-0140-6.Suche in Google Scholar PubMed PubMed Central

5. Park, SY, Gautier, JF, Chon, S. Assessment of insulin secretion and insulin resistance in human. Diabetes Metab J 2021;45:641–54. https://doi.org/10.4093/dmj.2021.0220.Suche in Google Scholar PubMed PubMed Central

6. Zhang, AMY, Wellberg, EA, Kopp, JL, Johnson, JD. Hyperinsulinemia in obesity, inflammation, and cancer. Diabetes Metab J 2021;45:285–311. https://doi.org/10.4093/dmj.2021.0131.Suche in Google Scholar PubMed PubMed Central

7. The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005;54:2404–14. https://doi.org/10.2337/diabetes.54.8.2404.Suche in Google Scholar PubMed PubMed Central

8. Kahn, SE, Lachin, JM, Zinman, B, Haffner, SM, Aftring, RP, Paul, G, et al.. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Diabetes 2011;60:1552–60. https://doi.org/10.2337/db10-1392.Suche in Google Scholar PubMed PubMed Central

9. Miller, WG, Thienpont, LM, Van Uytfanghe, K, Clark, PM, Lindstedt, P, Nilsson, G, et al.. Toward standardization of insulin immunoassays. Clin Chem. 2009;55:1011–8. https://doi.org/10.1373/clinchem.2008.118380.Suche in Google Scholar PubMed

10. Marcovina, S, Bowsher, RR, Miller, WG, Staten, M, Myers, G, Caudill, SP, et al.. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 2007;53:711–6. https://doi.org/10.1373/clinchem.2006.082214.Suche in Google Scholar PubMed

11. Staten, MA, Stern, MP, Miller, WG, Steffes, MW, Campbell, SE. Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care. Diabetes Care 2010;33:205–6. https://doi.org/10.2337/dc09-1206.Suche in Google Scholar PubMed PubMed Central

12. Foulon, N, Goonatilleke, E, MacCoss, MJ, Emrick, MA, Hoofnagle, AN. Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies. J Mass Spectrom Adv Clin Lab 2022;25:19–26. https://doi.org/10.1016/j.jmsacl.2022.06.003.Suche in Google Scholar PubMed PubMed Central

13. Moradian, A, Goonatilleke, E, Lin, TT, Hatten-Beck, M, Emrick, M, Schepmoes, AA, et al.. Interlaboratory comparison of antibody-free LC-MS/MS measurements of C-peptide and insulin. Clin Chem 2024;70:855–64. https://doi.org/10.1093/clinchem/hvae034.Suche in Google Scholar PubMed PubMed Central

14. Li, J, Hatten-Beck, M, Lee, JKY, Hoofnagle, AN. Insights into insulin analog cross-reactivity: a comparative study of Siemens Atellica and LC-MS/MS. Endocrine 2025;87:79–84. https://doi.org/10.1007/s12020-024-03970-6.Suche in Google Scholar PubMed PubMed Central

15. Tu, S, Li, C, Zeng, D, Shepherd, BE. Rank intraclass correlation for clustered data. Stat Med 2023;42:4333–48. https://doi.org/10.1002/sim.9864.Suche in Google Scholar PubMed PubMed Central

16. Passing, H, Bablok, W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709–20. https://doi.org/10.1515/cclm.1983.21.11.709.Suche in Google Scholar PubMed

17. Potapov, S, Model, F, Schuetzenmeister, A, Manuilova, E, Dufey, F, Raymaekers, J, et al.. Mcr: method comparison regression [Internet]. Version 1.3.3.1; 2024. Available from: https://CRAN.R-project.org/package=mcr [cited 9 Jun 2025].Suche in Google Scholar

18. Miller, WG, Myers, GL, Rej, R. Why commutability matters. Clin Chem. 2006;52:553–4. https://doi.org/10.1373/clinchem.2005.063511.Suche in Google Scholar PubMed

19. Rohlfing, C, Petroski, G, Connolly, SM, Hanson, S, Little, RR, Kabytaev, K. A comparative analysis of current C-peptide assays compared to a reference method: can we overcome inertia to standardization? Clin Chem Lab Med 2025;63:1124–31. https://doi.org/10.1515/cclm-2024-1260.Suche in Google Scholar PubMed PubMed Central

20. World Health Organization. WHO reference reagent for human insulin [internet]. WHO/BS/2019.2366. Available from: https://www.who.int/publications/m/item/WHO-BS-2019.2366 [cited 9 Jun 2025].Suche in Google Scholar

21. Teoli, J, Chikh, K, Jouini-Bouhamri, R, Charriere, S, Fabien, N, Raverot, V. When discordant insulin and C-peptide levels lead to a medical diagnosis in a patient with transient hypoglycemia: varying degrees of interference of insulin-antibody complexes on three insulin immunoassays. Heliyon 2024;10:e34009. https://doi.org/10.1016/j.heliyon.2024.e34009.Suche in Google Scholar PubMed PubMed Central

22. Sims, EK, Bahnson, HT, Nyalwidhe, J, Haataja, L, Davis, AK, Speake, C, et al.. Proinsulin secretion is a persistent feature of type 1 diabetes. Diabetes Care 2019;42:258–64. https://doi.org/10.2337/dc17-2625.Suche in Google Scholar PubMed PubMed Central

23. Cotes, PM, Mussett, MV, Berryman, I, Ekins, R, Glover, S, Hales, N, et al.. Collaborative study of estimates by radioimmunoassay of insulin concentrations in plasma samples examined in groups of five or six laboratories. J Endocrinol 1969;45:557–69. https://doi.org/10.1677/joe.0.0450557.Suche in Google Scholar PubMed

24. Rosli, N, Kwon, HJ, Lim, J, Yoon, YA, Jeong, JS. Measurement comparability of insulin assays using conventional immunoassay kits. J Clin Lab Anal 2022;36:e24521. https://doi.org/10.1002/jcla.24521.Suche in Google Scholar PubMed PubMed Central

25. Tohidi, M, Arbab, P, Ghasemi, A. Assay-dependent variability of serum insulin concentrations: a comparison of eight assays. Scand J Clin Lab Invest 2017;77:122–9. https://doi.org/10.1080/00365513.2016.1278260.Suche in Google Scholar PubMed

26. Zhou, W, Deng, Y, Zhao, H, Zhang, C. Current status of serum insulin and C-peptide measurement in clinical laboratories: experience from 94 laboratories in China. Ann Lab Med 2022;42:428–37. https://doi.org/10.3343/alm.2022.42.4.428.Suche in Google Scholar PubMed PubMed Central

Received: 2025-05-07
Accepted: 2025-07-31
Published Online: 2025-08-14
Published in Print: 2025-11-25

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Challenging the dogma: why reviewers should be allowed to use AI tools
  4. Multivariate approaches to improve the interpretation of laboratory data
  5. Review
  6. Interference of therapeutic monoclonal antibodies with electrophoresis and immunofixation of serum proteins: state of knowledge and systematic review
  7. Opinion Papers
  8. Urgent call to the European Commission to simplify and contextualize IVDR Article 5.5 for tailored and precision diagnostics
  9. The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference
  10. Supplementation of pyridoxal-5′-phosphate in aminotransferase reagents: a matter of patient safety
  11. HCV serology: an unfinished agenda
  12. From metabolic profiles to clinical interpretation: multivariate approaches to population-based and personalized reference intervals and reference change values
  13. Genetics and Molecular Diagnostics
  14. A multiplex allele specific PCR capillary electrophoresis (mASPCR-CE) assay for simultaneously analysis of SMN1/SMN2/NAIP copy number and SMN1 loss-of-function variants
  15. General Clinical Chemistry and Laboratory Medicine
  16. From assessment to action: experience from a quality improvement initiative integrating indicator evaluation and adverse event analysis in a clinical laboratory
  17. Evaluation of measurement uncertainty of 11 serum proteins measured by immunoturbidimetric methods according to ISO/TS 20914: a 1-year laboratory data analysis
  18. Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications
  19. The current status of serum insulin measurements and the need for standardization
  20. Method comparison of plasma and CSF GFAP immunoassays across multiple platforms
  21. Cerebrospinal fluid leptin in Alzheimer’s disease: relationship to plasma levels and to cerebrospinal amyloid
  22. Verification of the T50 Calciprotein Crystallization test: bias estimation and interferences
  23. An innovative immunoassay for accurate aldosterone quantification: overcoming low-level inaccuracy and renal dysfunction-associated interference
  24. Oral salt loading combined with postural stimulation tests for confirming and subtyping primary aldosteronism
  25. Evaluating the performance of a multiparametric IgA assay for celiac disease diagnosis
  26. Clinical significance of anti-mitochondrial antibodies and PBC-specific anti-nuclear antibodies in evaluating atypical primary biliary cholangitis with normal alkaline phosphatase levels
  27. Reference Values and Biological Variations
  28. Establishment of region-, age- and sex-specific reference intervals for aldosterone and renin with sandwich chemiluminescence immunoassays
  29. Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation
  30. Comparative analysis of population-based and personalized reference intervals for biochemical markers in peri-menopausal women: population from the PALM cohort study
  31. Hematology and Coagulation
  32. Evaluation of stability and potential interference on the α-thalassaemia early eluting peak and immunochromatographic strip test for α-thalassaemia --SEA carrier screening
  33. Cardiovascular Diseases
  34. Analytical and clinical evaluation of an automated high-sensitivity cardiac troponin I assay for whole blood
  35. Diabetes
  36. Method comparison of diabetes mellitus associated autoantibodies in serum specimens
  37. Letters to the Editor
  38. Permitting disclosed AI assistance in peer review: parity, confidentiality, and recognition
  39. Response to the editorial by Karl Lackner
  40. Hemolysis detection using the GEM 7000 at the point of care in a pediatric hospital setting: does it affect outcomes?
  41. Estimation of measurement uncertainty for free drug concentrations using ultrafiltration
  42. Cryoglobulin pre-analysis over the weekend
  43. Accelerating time from result to clinical action: impact of an automated critical results reporting system
  44. Recent decline in patient serum folate test levels using Roche Diagnostics Folate III assay
  45. Kidney stones consisting of 1-methyluric acid
  46. Congress Abstracts
  47. 7th EFLM Conference on Preanalytical Phase
  48. Association of Clinical Biochemists in Ireland Annual Conference
  49. Association of Clinical Biochemists in Ireland Annual Conference
  50. 17th Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine
Heruntergeladen am 1.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0552/html
Button zum nach oben scrollen